多重耐药性淋病：发现新药的研发路线图。
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
作者信息
Alirol Emilie, Wi Teodora E, Bala Manju, Bazzo Maria Luiza, Chen Xiang-Sheng, Deal Carolyn, Dillon Jo-Anne R, Kularatne Ranmini, Heim Jutta, Hooft van Huijsduijnen Rob, Hook Edward W, Lahra Monica M, Lewis David A, Ndowa Francis, Shafer William M, Tayler Liz, Workowski Kimberly, Unemo Magnus, Balasegaram Manica
机构信息
Global Antibiotics Research and Development Partnership (GARDP), Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
World Health Organization (WHO), Geneva, Switzerland.
出版信息
PLoS Med. 2017 Jul 26;14(7):e1002366. doi: 10.1371/journal.pmed.1002366. eCollection 2017 Jul.
Abstract
Emilie Alirol and colleagues discuss the development of new treatments for gonorrhea.
摘要
埃米莉·阿里罗尔及其同事讨论了淋病新疗法的研发情况。
相似文献
1
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.多重耐药性淋病：发现新药的研发路线图。
PLoS Med. 2017 Jul 26;14(7):e1002366. doi: 10.1371/journal.pmed.1002366. eCollection 2017 Jul.
2
In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents.西班牙淋病奈瑟菌分离株对头孢妥仑及其他五种抗菌药物的体外敏感性
Int J Antimicrob Agents. 2007 Apr;29(4):473-4. doi: 10.1016/j.ijantimicag.2006.10.014. Epub 2007 Feb 2.
3
Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae.脑膜炎奈瑟菌和淋病奈瑟菌的新兴耐药性。
Expert Rev Anti Infect Ther. 2011 Feb;9(2):237-44. doi: 10.1586/eri.10.171.
4
Prospects of untreatable gonorrhea and ways forward.无法治愈的淋病前景及未来方向。
Future Microbiol. 2015;10(3):313-6. doi: 10.2217/fmb.14.138.
5
Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa.南非耐环丙沙星淋病奈瑟菌
Int J Antimicrob Agents. 2004 Aug;24(2):192-3. doi: 10.1016/j.ijantimicag.2004.04.003.
6
Disseminated gonococcal infection in an immunocompetent patient caused by an imported Neisseria gonorrhoeae multidrug-resistant strain.一名免疫功能正常患者因输入的耐多药淋病奈瑟菌菌株导致播散性淋球菌感染。
J Clin Microbiol. 2006 Oct;44(10):3833-4. doi: 10.1128/JCM.01041-06.
7
Future treatment of gonorrhea--novel emerging drugs are essential and in progress?淋病的未来治疗——新型药物至关重要且正在研发中？
Expert Opin Emerg Drugs. 2015 Sep;20(3):357-60. doi: 10.1517/14728214.2015.1039981. Epub 2015 Jul 3.
8
Treatment of gonorrhea: what effect will antibiotic resistance have in the future?淋病的治疗：抗生素耐药性在未来会产生什么影响？
Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):120-5.
9
Antimicrobial resistance in Neisseria gonorrhoeae and limited treatment options.淋病奈瑟菌中的抗菌药物耐药性及有限的治疗选择。
J Pak Med Assoc. 2007 Jul;57(7):333-4.
10
Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.一家艾滋病毒/艾滋病诊所中淋病奈瑟菌的抗菌药物耐药性流行情况。
Int J STD AIDS. 2006 Jun;17(6):410-2. doi: 10.1258/095646206777323427.
引用本文的文献
1
Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacin.面对日益增加的抗菌药物耐药性，关于最佳引入新型抗生素治疗单纯性淋病的建议：以佐利氟达辛为例的案例研究
BMC Glob Public Health. 2024 Sep 3;2(1):58. doi: 10.1186/s44263-024-00087-w.
2
Thiazoplanomicin, a new thiazolyl peptide antibiotic from the leaf-litter actinomycete Actinoplanes sp. MM794L-181F6.噻唑普那霉素，一种从落叶层放线菌游动放线菌属MM794L-181F6中分离得到的新型噻唑基肽类抗生素。
J Antibiot (Tokyo). 2025 Jan;78(1):14-25. doi: 10.1038/s41429-024-00783-7. Epub 2024 Oct 28.
3
Structural and functional diversity of Resistance-Nodulation-Division (RND) efflux pump transporters with implications for antimicrobial resistance.耐药-结节-分裂（RND）外排泵转运蛋白的结构和功能多样性及其对抗菌药物耐药性的影响。
Microbiol Mol Biol Rev. 2024 Sep 26;88(3):e0008923. doi: 10.1128/mmbr.00089-23. Epub 2024 Sep 5.
4
Addressing Sexually Transmitted Infections Due to in the Present and Future.应对当前及未来由……引起的性传播感染 。
你提供的原文中“due to”后面似乎缺失了具体内容。
Microorganisms. 2024 Apr 28;12(5):884. doi: 10.3390/microorganisms12050884.
5
The Evaluation of Teleost-Derived Antimicrobial Peptides Against Neisseria gonorrhoeae.硬骨鱼源抗菌肽对淋病奈瑟菌的评估
Cureus. 2024 Mar 29;16(3):e57168. doi: 10.7759/cureus.57168. eCollection 2024 Mar.
6
Antimicrobial resistance and heterogeneity of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Lusaka, Zambia.赞比亚卢萨卡性传播感染门诊分离的淋病奈瑟菌的耐药性和异质性。
BMC Genomics. 2024 Mar 18;25(1):290. doi: 10.1186/s12864-024-10155-y.
7
Treatment Rates for Chlamydia trachomatis and Neisseria gonorrhoeae in a Metropolitan Area: Observational Cohort Analysis.大都市地区沙眼衣原体和淋病奈瑟菌的治疗率：观察性队列分析
Sex Transm Dis. 2024 May 1;51(5):313-319. doi: 10.1097/OLQ.0000000000001930. Epub 2024 Jan 23.
8
Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved SliC antigen that blocks human lysozyme.开发一种标签/捕获介导的衣壳病毒样颗粒疫苗，展示保守的 SliC 抗原，该抗原可阻断人溶菌酶。
Infect Immun. 2023 Dec 12;91(12):e0024523. doi: 10.1128/iai.00245-23. Epub 2023 Nov 2.
9
Towards the sustainable discovery and development of new antibiotics.迈向新型抗生素的可持续发现与开发。
Nat Rev Chem. 2021 Oct;5(10):726-749. doi: 10.1038/s41570-021-00313-1. Epub 2021 Aug 19.
10
Population-level predictors of sexually transmitted infection rate changes in Missouri: an ecological study.密苏里州性传播感染率变化的人群水平预测因素：一项生态学研究。
Arch Public Health. 2023 Jan 23;81(1):12. doi: 10.1186/s13690-022-01019-6.
本文引用的文献
1
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.淋病奈瑟菌的抗菌药物耐药性：全球监测及国际合作行动呼吁
PLoS Med. 2017 Jul 7;14(7):e1002344. doi: 10.1371/journal.pmed.1002344. eCollection 2017 Jul.
2
Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium.抗菌药物耐药的性传播感染：淋病和生殖支原体。
Nat Rev Urol. 2017 Mar;14(3):139-152. doi: 10.1038/nrurol.2016.268. Epub 2017 Jan 10.
3
Australian Gonococcal Surveillance Programme, 1 April to 30 June 2016.澳大利亚淋病监测项目，2016年4月1日至6月30日。
Commun Dis Intell Q Rep. 2016 Dec 24;40(4):E557-E559. doi: 10.33321/cdi.2016.40.65.
4
Sexually transmitted diseases and infertility.性传播疾病与不孕不育。
Am J Obstet Gynecol. 2017 Jan;216(1):1-9. doi: 10.1016/j.ajog.2016.08.008.
5
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家310种疾病和损伤的发病率、患病率及伤残调整生命年：全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6.
6
Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013.2000 - 2013年美国淋球菌对超广谱头孢菌素、大环内酯类和氟喹诺酮类耐药的基因组流行病学
J Infect Dis. 2016 Nov 15;214(10):1579-1587. doi: 10.1093/infdis/jiw420. Epub 2016 Sep 16.
7
Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea.双重抗菌疗法治疗淋病失败
N Engl J Med. 2016 Jun 23;374(25):2504-6. doi: 10.1056/NEJMc1512757.
8
Trends in condom use among MSM in the United States: the role of antiretroviral therapy and seroadaptive strategies.美国男男性行为者使用避孕套的趋势：抗逆转录病毒疗法和血清适应性策略的作用。
AIDS. 2016 Jul 31;30(12):1985-90. doi: 10.1097/QAD.0000000000001139.
9
In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens.新型三氮杂苊烯细菌拓扑异构酶抑制剂格波达辛对多种细菌病原体的体外活性
Antimicrob Agents Chemother. 2016 Jan 4;60(3):1918-23. doi: 10.1128/AAC.02820-15.
10
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting.基于系统评价和全球报告的2012年四种可治愈性传播感染的患病率和发病率全球估计
PLoS One. 2015 Dec 8;10(12):e0143304. doi: 10.1371/journal.pone.0143304. eCollection 2015.
Zotero 插件